Short-term, high-dose prednisolone doesn't raise diabetes risk in RA patients

03/21/2012 |

Short-term treatment with 60 mg or 30 mg per day of prednisolone, a type of corticosteroid, did not appear to lower glucose tolerance in rheumatoid arthritis patients, including those with impaired glucose metabolism or type 2 diabetes. The study in Arthritis & Rheumatism also found that patients who took prednisolone had improvements in C-reactive protein levels and, for those on the 60 mg per day dose, improved beta cell function.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN